{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:04:23Z","timestamp":1780697063536,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clon.2019.09.054","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T23:41:31Z","timestamp":1570750891000},"page":"e60-e66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials"],"prefix":"10.1016","volume":"32","author":[{"given":"H.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Conibear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Nabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Eaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Naismith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Whilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2019.09.054_bib1","series-title":"Radiotherapy target volume definition and peer review \u2013 RCR guidance","author":"The Royal College of Radiologists","year":"2017"},{"key":"10.1016\/j.clon.2019.09.054_bib3","series-title":"Safety is no accident: a framework for quality radiation oncology and care","author":"Zeitman","year":"2012"},{"key":"10.1016\/j.clon.2019.09.054_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.prro.2018.12.003","article-title":"Standardizing normal tissue contouring for radiation therapy treatment planning: executive summary of an ASTRO consensus paper","volume":"9","author":"Wright","year":"2019","journal-title":"Pract Rad Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib5","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.ijrobp.2011.09.054","article-title":"Standardizing naming conventions in radiation oncology","volume":"83","author":"Santanam","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2017.12.013","article-title":"American association of physicists in medicine task group 263: standardizing nomenclatures in radiation oncology","volume":"100","author":"Mayo","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib7","series-title":"The Delphi method: an experimental study","author":"Dalkey","year":"1969"},{"key":"10.1016\/j.clon.2019.09.054_bib8","series-title":"Group techniques for program planning","author":"Delbecq","year":"1975"},{"key":"10.1016\/j.clon.2019.09.054_bib9","series-title":"Safety is no accident: a framework for quality radiation oncology and care","author":"Zietman","year":"2012"},{"key":"10.1016\/j.clon.2019.09.054_bib10","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative Analysis of Normal Tissue Effected in the Clinic (QUANTEC): An introduction to the scientific issues","volume":"73","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib11","series-title":"NHS England Radiotherapy Service Specification Report: 170092S,","year":"2019"},{"key":"10.1016\/j.clon.2019.09.054_bib12","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.clon.2012.06.006","article-title":"Radiotherapy quality assurance: facilitation of radiotherapy research and implementation of technology","volume":"24","author":"Miles","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2012.06.010","article-title":"Does participation in clinical trials influence the implementation of new techniques? A look at changing techniques in breast radiotherapy in the UK","volume":"24","author":"Venables","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2014.09.003","article-title":"Quality assurance standards drive improvements in the profile of radiation therapy departments participating in trials of the EORTC Radiation Oncology Group","volume":"112","author":"Grant","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib15","doi-asserted-by":"crossref","first-page":"20150453","DOI":"10.1259\/bjr.20150453","article-title":"Clinical impact of IMPORT High trial (CRUK\/06\/003) on breast radiotherapy practices in the United Kingdom","volume":"88","author":"Tsang","year":"2015","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2019.09.054_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0360-3016(98)00216-8","article-title":"Variability of target volume delineation in cervical esophageal cancer","volume":"42","author":"Tai","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1259\/bjr\/27674581","article-title":"A\u00a0novel algorithm for the morphometric assessment of radiotherapy treatment planning volumes","volume":"83","author":"Jena","year":"2010","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2019.09.054_bib18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0360-3016(02)02752-9","article-title":"Improving the consistency in cervical esophageal target volume definition by special training","volume":"53","author":"Tai","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ijrobp.2012.01.094","article-title":"Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case","volume":"84","author":"Gwynne","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tipsro.2019.05.001","article-title":"Assessment of contour variability in target volumes and organs at risk in lung cancer radiotherapy","volume":"10","author":"Tsang","year":"2019","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.radonc.2017.12.013","article-title":"The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology","volume":"128","author":"Eekers","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13014-019-1262-8","article-title":"A\u00a0systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy","volume":"14","author":"Jadon","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S1470-2045(17)30318-2","article-title":"Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial","volume":"18","author":"Faivre-Finn","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2019.09.054_bib24","doi-asserted-by":"crossref","first-page":"20130653","DOI":"10.1259\/bjr.20130653","article-title":"Is pre-trial quality assurance necessary? Experiences of the CONVERT phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer","volume":"87","author":"Groom","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2019.09.054_bib25","doi-asserted-by":"crossref","first-page":"20170036","DOI":"10.1259\/bjr.20170036","article-title":"Effect of accurate heart delineation on cardiac dose during the CONVERT trial","volume":"90","author":"Groom","year":"2017","journal-title":"Br J Radiol"},{"key":"10.1016\/j.clon.2019.09.054_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","article-title":"Radiation dose to heart base linked with poorer survival in lung cancer patients","volume":"85","author":"McWilliam","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clon.2019.09.054_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijrobp.2018.05.052","article-title":"Residual setup errors towards the heart after image guidance linked with poorer survival in lung cancer patients: do we need stricter IGRT protocols?","volume":"102","author":"Johnson","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib28","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.ijrobp.2016.03.031","article-title":"IDEAL-CRT: A phase 1\/2 trial of isotoxic dose-escalated radiation therapy and concurrent chemotherapy in patients with stage II\/III non-small cell lung cancer","volume":"95","author":"Landau","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2019.09.054_bib29","article-title":"Protocol for the isotoxic intensity modulated radiotherapy (IMRT) in stage III non-small cell lung cancer (NSCLC): a feasibility study","volume":"6","author":"Haslett","year":"2016","journal-title":"Br Med J Open"},{"key":"10.1016\/j.clon.2019.09.054_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2019.03.009","article-title":"Individualized accelerated isotoxic concurrent chemo-radiotherapy for stage III non-small cell lung cancer: 5-year results of a prospective study","volume":"135","author":"De Ruysscher","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519304339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655519304339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:47:20Z","timestamp":1760543240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655519304339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0936655519304339"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2019.09.054","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2019.09.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2019 Published by Elsevier Ltd on behalf of The Royal College of Radiologists. All rights reserved.","name":"copyright","label":"Copyright"}]}}